Literature DB >> 3011842

Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects.

I Berlin, A Grimaldi, F Bosquet, A J Puech.   

Abstract

To study beta-adrenergic sensitivity in diabetes mellitus, we performed isoproterenol sensitivity tests in 34 insulin-dependent diabetic patients and 10 age-matched normal subjects. beta-adrenergic sensitivity [defined as the dose of isoproterenol required to increase the resting heart rate by 25 beat/min, (I25)] was significantly higher in the diabetic group (4.07 +/- 1.4 micrograms, mean +/- SD) than in the normal group (2.02 +/- 1.49 micrograms). A comparison of I25 of normal subjects and diabetic patients as a function of age showed that the latter were significantly less sensitive to beta-adrenergic stimulation at all ages (P less than 0.01). In diabetic patients, beta-adrenergic sensitivity also increased with the duration of diabetes (r = 0.64, P less than 0.0005), but the correlation was stronger when the age of the patients and the duration of the diabetes were both taken into consideration (r = 0.72, P less than 0.0005). We conclude that beta-adrenergic sensitivity is diminished in patients with type I diabetes mellitus of all ages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011842     DOI: 10.1210/jcem-63-1-262

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 3.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

4.  Cardiovascular sequelae of endotoxin shock in diabetic dogs.

Authors:  W R Law; M T Moriarty; M P McLane
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

5.  Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness.

Authors:  T S Trovik; R Jaeger; R Jorde; G Sager
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.

Authors:  T S Trovik; R Jaeger; R Jorde; O Ingebretsen; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.

Authors:  Ronald B Myers; Gregory M Fomovsky; Samuel Lee; Max Tan; Bing F Wang; Parth Patwari; Jun Yoshioka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-01       Impact factor: 4.733

8.  Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes.

Authors:  P D Morrison; M W Mackinnon; J T Bartrup; P G Skett; T W Stone
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

Review 9.  Drug administration in patients with diabetes mellitus. Safety considerations.

Authors:  R E Gilbert; M E Cooper; H Krum
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

10.  Protein kinase C modulation of the regulation of sarcoplasmic reticular function by protein kinase A-mediated phospholamban phosphorylation in diabetic rats.

Authors:  Satoko Watanuki; Naoyuki Matsuda; Fumika Sakuraya; Subrina Jesmin; Yuichi Hattori
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.